Dihydroartemisinin-piperaquine or sulphadoxine-pyrimethamine for the chemoprevention of malaria in children with sickle cell anaemia in eastern and southern Africa (CHEMCHA): a protocol for a multi-centre, two-arm, double-blind, randomised, placebo-controlled superiority trial.

MLA

Nkosi-Gondwe, Thandile, et al. “Dihydroartemisinin-Piperaquine or Sulphadoxine-Pyrimethamine for the Chemoprevention of Malaria in Children with Sickle Cell Anaemia in Eastern and Southern Africa (CHEMCHA): A Protocol for a Multi-Centre, Two-Arm, Double-Blind, Randomised, Placebo-Controlled Superiority Trial.” Trials, vol. 24, no. 1, Apr. 2023, p. 257. EBSCOhost, https://doi.org/10.1186/s13063-023-07274-4.

APA

Nkosi-Gondwe, T., Robberstad, B., Opoka, R., Kalibbala, D., Rujumba, J., Galileya, L. T., Akun, P., Nambatya, W., Ssenkusu, J., TerKuile, F., Phiri, K., & Idro, R. (2023). Dihydroartemisinin-piperaquine or sulphadoxine-pyrimethamine for the chemoprevention of malaria in children with sickle cell anaemia in eastern and southern Africa (CHEMCHA): a protocol for a multi-centre, two-arm, double-blind, randomised, placebo-controlled superiority trial. Trials, 24(1), 257. https://doi.org/10.1186/s13063-023-07274-4

Chicago

Nkosi-Gondwe, Thandile, Bjarne Robberstad, Robert Opoka, Dennis Kalibbala, Joseph Rujumba, Lufina Tsirizani Galileya, Pamela Akun, et al. 2023. “Dihydroartemisinin-Piperaquine or Sulphadoxine-Pyrimethamine for the Chemoprevention of Malaria in Children with Sickle Cell Anaemia in Eastern and Southern Africa (CHEMCHA): A Protocol for a Multi-Centre, Two-Arm, Double-Blind, Randomised, Placebo-Controlled Superiority Trial.” Trials 24 (1): 257. doi:10.1186/s13063-023-07274-4.